
- Mount Sinai Doctors
- Treats Adults
- Accepting New Patients
Samantha E Jacobs, MD
Infectious Disease
About Me
Samantha E. Jacobs, MD, is an Associate Professor in the Division of Infectious Diseases. She is board certified in Infectious Diseases and Internal Medicine.
Dr. Jacobs specializes in the prevention and management of infections in immunocompromised hosts, including solid organ and hematopoietic stem cell transplant recipients. Her research interests include respiratory viral infections and invasive fungal diseases in immunocompromised hosts.
Language
English
Position
ASSOCIATE PROFESSOR | Medicine, Infectious Diseases
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
Clinical Focus
- Endocarditis
- Fungal Infections
- Hepatitis A Vaccine
- Hepatitis B Vaccine
- Hepatitis C Testing
- Hospital Acquired Infections
- Japanese Encephalitis Vaccine
- Liver Abscess
- MRSA
- Meningococcal Vaccine
- Non-bacterial Lung Infection
- Non-tuberculous Mycobacterial Infections
- Opportunistic Infections
- Osteomyelitis
- PrEP/nPEP
- Shingles
- Syphilis
- Tetanus Vaccine
- Travel Medicine
- Tropical Disease / Parasite / Malaria
- Tuberculosis
- Typhoid Vaccine
- Varicella Vaccine
- Yellow Fever Vaccine
Education
MD, Perelman School Of Medicine At The University Of Pennsylvania
MS, Weill Cornell Graduate School of Medical Sciences
Residency, The Mount Sinai Hospital
Residency, Internal Medicine
Mount Sinai Hospital
Fellowship, Infectious Disease
Weill Cornell Medical College-New York Hospital
Certifications
American Board of Internal Medicine
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information. Patients with Anthem Blue Cross Blue Shield (formerly known as Empire) please click here for more information. Patients with Molina insurance should click here for more information. Mount Sinai’s contracts with Anthem and Molina expired on December 31.
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- Affinity Medicaid-Medicare-Essential Exchange
- Amidacare Medicaid
- CIGNA Healthcare
- Centivo
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicaid
- EmblemHealth - HIP-Medicare
- Empire Blue Cross Blue Shield - Commercial/Exchange
- Empire Blue Cross Blue Shield - HealthPlus Medicaid
- Empire Blue Cross Blue Shield - Medicare
- Fidelis Health Care
- HealthFirst Medicaid
- HealthFirst Medicare
- Horizon NJ
- Magnacare-Health Care
- Medicare - NY
- Metroplus
- Multiplan PHCS
- NY Medicaid
- Oscar
- Oxford - Freedom and Liberty
- Senior Whole Health
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
- VNSNY Choice Medicare
- VNSNY Select Health Medicaid
- VillageCareMax
- WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Early de-escalation of empiric antibiotic therapy in neutropenic fever: a single-center, retrospective study. Zachary Mostel, Michelle Evans, Douglas Tremblay, Meenakshi Rana, Samantha E. Jacobs, John Mascarenhas, Alla Keyzner, Daniel Park, Risa Fuller. Antimicrobial Stewardship and Healthcare Epidemiology
- COVID-19 Breakthrough Infections in Severely Immunocompromised Patients Who Received Tixagevimab/Cilgavimab for Pre-exposure Prophylaxis. Bayan Alahmdi, Judith Aberg, Gopi Patel, Samantha E. Jacobs, Meenakshi Rana. Infectious Diseases in Clinical Practice
- Invasive Fungal Diseases in Patients With Multiple Myeloma: Experience at a Large, Urban Referral Center. Emily Baneman, Alan Weinberg, Timothy Sullivan, Risa Fuller, Dallas Dunn, Sarah Taimur, Meenakshi Rana, Samantha E. Jacobs. Transplant Infectious Disease
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Jacobs during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Ansun BioPharma
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.